Case number 1:22-cv-00896
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 8, 2022 | 19 | SCHEDULING & CONSOLIDATION ORDER: THESE ACTIONS ARE CONSOLIDATED FOR ALL PURPOSES AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-CV-856-CFC ONLY. The caption shall be modified to include the words "ANDA CASE" immediately below the civil action number. Joinder of Parties due by 8/25/2023. Amended Pleadings due by 8/25/2023. Fact Discovery completed by 10/6/2023. Expert Discovery due by 2/16/2024. Joint Claim Construction Brief due by 6/9/2023. A Markman Hearing is set for 7/11/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 4/16/2024. A Final Pretrial Conference is set for 5/7/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 5/13/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 11/8/2022. (nmf) (Entered: 11/08/2022) (30) |
| Oct 27, 2022 | 18 | PROPOSED ORDER -- [Proposed] Scheduling Order -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Murray, Travis) (Entered: 10/27/2022) (Main Document) (30) |
| Oct 27, 2022 | 18 | PROPOSED ORDER -- [Proposed] Scheduling Order -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Murray, Travis) (Entered: 10/27/2022) (Letter to The Honorable Colm F. Connolly) (1) |
| Oct 20, 2022 | 17 | STIPULATION TO EXTEND TIME for the parties to file a proposed scheduling order to October 27, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/20/2022) (2) |
| Oct 7, 2022 | 16 | Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding the Court's Order on coordination of related cases - re (14 in 1:22-cv-00896-CFC, 14 in 1:22-cv-00896-CFC) Order,,, Set Deadlines,, (16 in 1:22-cv-00937-CFC, 16 in 1:22-cv-00937-CFC) Order,,, Set Deadlines,, (13 in 1:22-cv-00856-CFC, 13 in 1:22-cv-00856-CFC) Order,,, Set Deadlines,,. (Egan, Brian) (Entered: 10/07/2022) (2) |
| Oct 4, 2022 | 15 | ANSWER to 11 Answer to Complaint, Counterclaim (Plaintiffs' Answer to Sun Pharmaceutical Industries Ltd.'s Counterclaims) - by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/04/2022) (30) |
| Sep 20, 2022 | 14 | ORDER, These cases having been recently joined and as these cases are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before October 20, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 10/20/2022.) Signed by Judge Colm F. Connolly on 9/20/2022. (nmf) (Entered: 09/20/2022) (2) |
| Sep 14, 2022 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson and Kimberly A. Beis - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Vrana, Robert) (Entered: 09/14/2022) (6) |
| Sep 13, 2022 | 11 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Ltd..(Gaza, Anne) (Entered: 09/13/2022) (30) |
| Sep 13, 2022 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Sun Pharmaceutical Industries, Inc. filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Gaza, Anne) (Entered: 09/13/2022) (3) |
| Sep 2, 2022 | 10 | STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to September 13, 2022 - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Gaza, Anne) (Entered: 09/02/2022) (2) |
| Aug 22, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 08/22/2022) (12) |
| Jul 19, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries, Inc. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Jul 19, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries Ltd. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Jul 6, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 1, 2022 | 1 | Main Document (26) Docket Text: COMPLAINT filed against Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. ( Filing fee $ 402, receipt number ADEDC-3908427.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibit A-S, # (2) Civil Cover Sheet)(smg) |
| Jul 1, 2022 | 1 | Exhibit A-S (330) |
| Jul 1, 2022 | 1 | Civil Cover Sheet (2) |
| Jul 1, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jul 1, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/19/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/19/2024. (smg) |
| Jul 1, 2022 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (smg) |
| Jul 1, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo A/S for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc. (smg) |
| Jul 1, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to Sun Pharmaceutical Industries Ltd. on 7/1/2022; Sun Pharmaceutical Industries, Inc. on 7/1/2022. (Attachments: # (1) Summons Issued)(smg) |
| Jul 1, 2022 | 6 | Summons Issued (2) |
| Jul 1, 2022 | 1 | Complaint* (1) |
